Gao Liu

841 total citations
17 papers, 650 citations indexed

About

Gao Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gao Liu has authored 17 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Gao Liu's work include MicroRNA in disease regulation (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and interferon and immune responses (2 papers). Gao Liu is often cited by papers focused on MicroRNA in disease regulation (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and interferon and immune responses (2 papers). Gao Liu collaborates with scholars based in China, Ethiopia and United States. Gao Liu's co-authors include Benjamin J. Doranz, Ellen L. Berg, Robert W. Doms, Cédric Blanpain, Stewart R. Durell, Yong Yi, Monica Tsang, Chung Nan Chang, Bao‐Ye Sun and H. Robert Guy and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Gao Liu

15 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gao Liu China 11 284 254 237 151 128 17 650
Michael Schauer Germany 8 111 0.4× 238 0.9× 62 0.3× 80 0.5× 48 0.4× 11 629
Manuela Bragardo Italy 15 550 1.9× 246 1.0× 104 0.4× 144 1.0× 28 0.2× 19 934
Travis J. Friesen United States 8 238 0.8× 151 0.6× 83 0.4× 162 1.1× 25 0.2× 10 502
Ramona Ilari Italy 12 202 0.7× 382 1.5× 72 0.3× 91 0.6× 196 1.5× 19 626
Donatella Buonfiglio Italy 12 429 1.5× 153 0.6× 86 0.4× 112 0.7× 26 0.2× 15 645
Zhengke Li United States 15 98 0.3× 457 1.8× 57 0.2× 173 1.1× 122 1.0× 23 636
Di Qin China 16 120 0.4× 275 1.1× 54 0.2× 363 2.4× 196 1.5× 22 712
Jocelyn S. Downey United Kingdom 7 132 0.5× 334 1.3× 27 0.1× 141 0.9× 109 0.9× 11 536
Flavia Bottarel Italy 11 341 1.2× 183 0.7× 98 0.4× 70 0.5× 34 0.3× 15 580
Michela Riba Italy 14 161 0.6× 252 1.0× 25 0.1× 120 0.8× 44 0.3× 25 504

Countries citing papers authored by Gao Liu

Since Specialization
Citations

This map shows the geographic impact of Gao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gao Liu more than expected).

Fields of papers citing papers by Gao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gao Liu. The network helps show where Gao Liu may publish in the future.

Co-authorship network of co-authors of Gao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Gao Liu. A scholar is included among the top collaborators of Gao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gao Liu. Gao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Wei, Cheng Zhou, Gao Liu, et al.. (2025). PCK1 and ALDH1A1 are identified as biomarkers for inherent drug resistance in hepatocellular carcinoma. Discover Oncology. 16(1). 1626–1626.
3.
Guan, Ruo‐Yu, Zhangfu Yang, Bao‐Ye Sun, et al.. (2024). Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis. Cancer Medicine. 13(23). e70459–e70459. 1 indexed citations
4.
Sun, Bao‐Ye, Zhangfu Yang, Zhu-Tao Wang, et al.. (2023). Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma. World Journal of Surgical Oncology. 21(1). 90–90. 13 indexed citations
5.
Liu, Gao, Zhangfu Yang, Jian Sun, et al.. (2022). The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth. Cellular Oncology. 45(6). 1435–1449. 17 indexed citations
6.
Sun, Bao‐Ye, Cheng Zhou, Ruo‐Yu Guan, et al.. (2022). Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis. Frontiers in Immunology. 13. 871769–871769. 27 indexed citations
7.
Liu, Gao, Jian Sun, Zhangfu Yang, et al.. (2021). Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death and Disease. 12(3). 260–260. 95 indexed citations
8.
Liu, Gao, Bao‐Ye Sun, Jian Sun, et al.. (2021). BRG1 regulates lipid metabolism in hepatocellular carcinoma through the PIK3AP1/PI3K/AKT pathway by mediating GLMP expression. Digestive and Liver Disease. 54(5). 692–700. 11 indexed citations
9.
Yi, Yong, Mincheng Yu, Pei‐Yao Fu, et al.. (2021). MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K/AKT by translocating β‐catenin and predicts poor prognosis. Liver International. 41(6). 1409–1420. 4 indexed citations
10.
Huang, Jinlong, Yi‐Peng Fu, Wei Gan, et al.. (2020). Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis. Cancer Letters. 476. 140–151. 53 indexed citations
11.
Liu, Gao, Zhangfu Yang, Pei‐Yun Zhou, et al.. (2020). ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5. Cytokine. 129. 155004–155004. 15 indexed citations
12.
Ni, Xiaochun, Jie Xu, Yong Yi, et al.. (2019). Inflammation–nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma. International Journal of Clinical Oncology. 24(7). 825–835. 7 indexed citations
13.
Pu, Ning, Qiangda Chen, Shanshan Gao, et al.. (2019). Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. Annals of Translational Medicine. 7(22). 645–645. 28 indexed citations
14.
Fang, Yu, Guoxing Liu, Chengzhi Xie, et al.. (2018). Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway. Biomedicine & Pharmacotherapy. 101. 910–919. 46 indexed citations
15.
Liu, Gao, Chi Mao, Guang‐Yan Yu, & Xin Peng. (2016). [Authorization, translation, back translation and language modification of the simplified Chinese adult comorbidity-27 index].. PubMed. 51(10). 623–627. 1 indexed citations
16.
Shao, Kun, Yun Lu, Jingyi Wang, et al.. (2015). Different Effects of Tacrolimus on Innate and Adaptive Immune Cells in the Allograft Transplantation. Scandinavian Journal of Immunology. 83(2). 119–127. 18 indexed citations
17.
Lee, Benhur, Matthew Sharron, Cédric Blanpain, et al.. (1999). Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function. Journal of Biological Chemistry. 274(14). 9617–9626. 314 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026